These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15169578)

  • 1. PCOS: a diagnostic challenge.
    Azziz R
    Reprod Biomed Online; 2004 Jun; 8(6):644-8. PubMed ID: 15169578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
    Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
    Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic criteria for polycystic ovary syndrome].
    Lauritsen MP; Svendsen PF; Andersen AN
    Ugeskr Laeger; 2019 Apr; 181(15):. PubMed ID: 30990163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How polycystic ovary syndrome came into its own.
    Azziz R
    F S Sci; 2021 Feb; 2(1):2-10. PubMed ID: 35559761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
    Skiba MA; Islam RM; Bell RJ; Davis SR
    Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis.
    Christ JP; Gunning MN; Fauser BCJM
    Reprod Biomed Online; 2017 Oct; 35(4):480-483. PubMed ID: 28733169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
    Franks S
    J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.